Perrigo Company plc (LON:0Y5E)

Market Cap	1.07B -60.5%
Revenue (ttm)	3.14B -3.6%
Net Income	-1.37B
EPS	-9.86
Shares Out	n/a
PE Ratio	n/a
Forward PE	4.77
Dividend	0.86 (8.25%)
Ex-Dividend Date	May 29, 2026

Volume	72
Open	10.55
Previous Close	10.48
Day's Range	10.22 - 10.55
52-Week Range	9.28 - 28.52
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	May 6, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Y5E

Financial Performance

In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.

Financial numbers in USD